News Releases | Lexicon Pharmaceuticals, Inc.

Press Releases

Lexicon Pharmaceuticals to Host Conference Call and Webcast Today, March 22, 2019 to Provide a Regulatory Update on Sotagliflozin in Type 1 Diabetes	Mar 22, 2019
FDA Issues Complete Response Letter for Zynquista™ (Sotagliflozin)	Mar 22, 2019
Lexicon Pharmaceuticals Announces Dosing of First Patient in TELE-ABC Study, a Phase 2a Clinical Study of Telotristat Ethyl in Biliary Tract Cancer	Mar 15, 2019
Lexicon Pharmaceuticals Reports Fourth Quarter and Full-Year 2018 Financial Results and Provides a Business Update	Mar 13, 2019
Lexicon Pharmaceuticals to Host Fourth Quarter and Full-Year 2018 Financial Results Conference Call and Webcast on March 13, 2019	Mar 11, 2019
Lexicon Pharmaceuticals to Present at Upcoming Investor Conference	Mar 11, 2019
CHMP Recommends Zynquista™ (Sotagliflozin) for the Treatment of Adults with Type 1 Diabetes	Mar 01, 2019
Lexicon Pharmaceuticals Announces Poster Presentations at the 16th Annual ENETS Conference	Feb 28, 2019
FDA Advisory Committee Votes on Zynquista™ (Sotagliflozin) as Treatment for Adults with Type 1 Diabetes	Jan 17, 2019
Lexicon Pharmaceuticals to Host Conference Call and Webcast on January 17, 2019 to Discuss Outcome of FDA Advisory Committee Meeting for Sotagliflozin in Type 1 Diabetes	Jan 17, 2019